Cross-fund · 5 holders
ARWR
ARROWHEAD PHARMACEUTICALS IN
CUSIP 04280A100
5
Tracked holders
$2.18B
Aggregate value
33,947,086
Shares
6
Active funds
Funds holding ARWR
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $1.14B | 0.02% | −3,157,063 | −14.8% |
| Vanguard | Institutional | Q4 2025 | $1.02B | 0.01% | −742,749 | −4.6% |
| Citadel | Multi-Strategy | Q1 2026 | $22.0M | — | −424,565 | −54.8% |
| BridgewaterFEAT | Macro | Q1 2026 | $6.0M | 0.03% | +35,586 | +59.3% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $2.9M | — | +14,500 | +45.5% |
| Millennium | Multi-Strategy | Q1 2026 | — | — | −45,018 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.